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Background: The aim of this study was to describe the diagnosis and treatment patterns of male lower
urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) and evaluate their
appropriateness in an area without an urologist and with limited resources, such as the area covered by
Murjani General Hospital, Sampit, Indonesia.
Methods: This descriptive study used data collected from medical records of patients who were
diagnosed with LUTS suggestive of BPH in Murjani General Hospital between September 2013 and
August 2015.
Results: There were 89 patients. Their mean age was 64.5 years. The most common chief complaint was
inability to void (59.6%), followed by frequency (10.1%). Diagnostic evaluations such as symptom scoring
(1.1%), frequencyevolume chart (0%), digital rectal examination (3.4%), urinalysis (5.6%), and prostate-
speciﬁc antigen (0%) were used rarely or never, while renal function assessment (37.1%) and imaging
of the prostate (68.5%) and upper urinary tract (65.2%) were used more often. Overall, the treatment that
was administered most often was indwelling catheterization (25.8%); only 19.1% visited a urologist
following a referral by the physician, although 41.6% were referred to a urologist. There were 40.4% of
patients with an indication for surgery, mostly in the form of recurrent or refractory urinary retention
(83.3%). In this group of patients, only 38.9% received appropriate treatment in the form of open pros-
tatectomy by a general surgeon (16.7%) or were referred to a urologist (22.2%), while 50% of them were
managed with chronic indwelling catheterization.
Conclusion: All patients received substandard diagnostic evaluations, with a pattern of preference to-
ward imaging studies over more basic examinations for LUTSeBPH. The high frequency of indwelling
catheterization in overall and inappropriate treatment in the group of patients with an indication for
surgery showed that patients received suboptimal treatment. Improvements in various aspects are
required to optimize the management of LUTS suggestive of BPH in Murjani General Hospital.
Copyright © 2016 Asian Paciﬁc Prostate Society, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lower urinary tract symptoms (LUTS) suggestive of benign
prostatic hyperplasia (BPH) is a common and bothersome condition
in aging men.1 The prevalence of moderate to severe LUTS in men
ranges from 16.2% to 25.1%,1,2 while the prevalence of LUTS
described at least ‘sometimes’ and at least ‘often’ is 72.3% and 47.9%,
respectively.3 This prevalence increases with age,1,2 and the qualityurjani General Hospital, H. M.
.
ciﬁc Prostate Society, Published bof life has reduced signiﬁcantly among those with LUTS.1 Although
the etiology of male LUTS is multifactorial, one of themost common
causes of LUTS in older men is BPH, which induces benign prostatic
enlargement and benign prostatic obstruction.4 As the aging pop-
ulation in Indonesia is growing, with the elderly population
constituting 8.03% of the total population in 2014 and showing an
increasing trend,5 one can expect an increase in the number of men
with LUTS suggestive of BPH here.
Management of men with LUTS suggestive of BPH by urologists
and general practitioners in Indonesia has in part referred to cur-
rent guidelines.6,7 Unfortunately, as a developing country, health-
care resources in Indonesia are not distributed evenly. Urologistsy Elsevier. This is an open access article under the CC BY-NC-ND license (http://
Prostate Int 4 (2016) 65e6966are concentrated in Java Island, and outside Java Island they are
mostly located in province capitals. Owing to that, management
patterns of male LUTS suggestive of BPH in areas without urolo-
gist(s) and with limited healthcare resources, such as East Kota-
waringin Regency that is covered by Murjani General Hospital,
Sampit, Indonesia cannot be represented by those studies.
The general objectives of this study were to evaluate the diag-
nosis and treatment patterns of male LUTS suggestive of BPH in
Murjani General Hospital, and compared the results with available
guidelines to assess its appropriateness.
2. Materials and methods
This descriptive study used data retrospectively from medical
records of patients of Murjani General Hospital, during the 2-year
period from September 2013 to August 2015. Patients who were
diagnosed with male LUTS suggestive of BPH by a general practi-
tioner or a general surgeon and conﬁrmed by a general surgeon
were included in this study. The exclusion criteria were as follows:
(1) patients who were diagnosed with LUTS caused by conditions
other than BPH during follow-ups; (2) patients who had already
undergone prostate, bladder, or urethral surgery before the time of
diagnosis; and (3) patients who had already been treated for LUTS/
BPH by a urologist before the diagnosis.
The data collected included patients' age, health insurance, chief
complaint, performed or measured diagnostic evaluation, comor-
bid conditions, surgical history, indication for surgery, treatment
received, and treatment outcome.
3. Results
3.1. Sample characteristics
A total of 89 patients were included in this study. Patient char-
acteristics are shown in Table 1.
3.2. Diagnosis pattern
The chief complaints were inability to void (59.6%), frequency
(10.1%), intermittency (7.9%), straining (7.9%), incomplete emptying
(5.6%), nocturia (3.4%), and others (5.5%).
The performed or measured diagnostic evaluations were as
follows: symptom scoring using the International Prostate Symp-
tom Score (IPSS) in 1.1%, frequencyevolume charts (FVC) in 0%,
digital rectal examination (DRE) in 3.4%, urinalysis in 5.6%, prostate-
speciﬁc antigen (PSA) in 0%, renal function assessment in 37.1%,
imaging of the upper urinary tract in 65.2%, and imaging of the
prostate in 68.5%. No patients received the standard diagnostic
evaluation according to available LUTS/BPH guidelines.Table 1
Patients' characteristics
Variables Value







Type of health insurance
No insurance 43.8
National health insurance 45.0
District health insurance 11.2
Data are presented as n (%).The comorbid conditions found were hypertension (23.6%),
dyslipidemia (5.6%), heart disease (2.2%), Type 2 diabetes mellitus
(2.2%), gout (2.2%), asthma (1.1%), and nonhemorrhagic stroke
(1.1%). The surgical histories found were inguinal hernia repair
(3.4%), appendectomy (1.1%), and cholecystectomy (1.1%).
Of the patients, 40.4% had an indication for surgery. The in-
dications were recurrent or refractory urinary retention (83.3%),
bladder stones (8.3%), renal insufﬁciency (5.6%), and dilatation of
the upper urinary tract (2.8%). For the remaining patients, it could
not be determined whether they had any indication for surgery or
not because of the lack of diagnostic evaluations.
3.3. Treatment pattern
Overall, the patients were treated with watchful waiting (21.3%),
received medical treatment (21.3%), received surgical treatment in
the form of open prostatectomy (OP) by a general surgeon (12.4%),
were referred to a urologist (19.1%), and underwent indwelling
catheterization (25.8%); in patients with an indication for surgery,
with the same treatment option, the rates were 2.8%, 8.3%, 16.7%,
22.2%, and 50%, respectively.
In all, 37 patients (41.6%) were referred to a urologist by the
general surgeon. The factors that led to the referral were the
presence of an indication for surgery (62.2%), age > 70 years
(59.5%), and the presence of comorbid conditions that increased
surgical risk (48.6%). Fourteen patients (37.9%) visited a urologist
following the referral, while the rest refused and chose to be treated
with watchful waiting (5.4%), medical treatment (10.8%), surgical
treatment (10.8%), and indwelling catheterization (35.1%). Three
patients requested for a urologist referral without being advised by
the general surgeon.
3.4. Treatment outcome
The outcomes in the watchful waiting groups were improve-
ment (5.3%), unchanged (31.6%), deterioration (21.0%), and loss to
follow-up (42.1%). In the same order, the outcomes in the medical
treatment group were 42.1%, 26.3%, 10.5%, and 21.1%, respectively,
and those in the indwelling catheterization group were 21.8%,
30.4%, 13.0%, and 34.8%, respectively. In the surgical treatment
group, 90.9% reported improvement and 9.1% (1 sample) died in the
postoperative period. In the referred group, 23.5% reported
improvement and 76.5% were lost to follow-up. Those who
reported improvement in the referred group were all treated with
transurethral resection of the prostate by the urologist.
4. Discussion
Age distribution was represented by a bell-shaped curve, with
the peak in the 60e69-year-old group. It matched with the life
expectancy in East Kotawaringin, which was 69.56 years.8,9 The
usual linear progression of prevalence with aging1,2 could not be
demonstrated because of the small sample size, which prevented
these data from representing the true age distribution or preva-
lence in the population.
The most common chief complaint was inability to void (59.6%).
Its rate was similar to that reported in studies in Indonesia (55.5%)6
and Bahrain (42.95%)10; however, it was not a common complaint
in Europe (6.8%).11 This may be caused by the difference in
healthcare-seeking behavior of people of East Kotawaringin and
those of developed countries. Andersen12 suggested that three cat-
egories of factors determine how and whether individuals use
medical services, which were predisposing factors (e.g., health be-
liefs, attitudes, and education), enabling factors (e.g., income, health
insurance, geographic proximity, and clinic waiting times), and need
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accepted urinary symptoms as a normal part of aging13e15; 49.52% of
the people in East Kotawaringin had only elementary school degree
andonly4.54%hadauniversitydegree9; and8.37%of thepeoplewere
categorized as poor, with 2.08% being openly unemployed; the
Healthcare and Social Security Agency (national health insurance in
Indonesia) had not covered most citizens, with only 44.9% of the
patients being coveredby it; andgeographic access to healthcarewas
difﬁcult, with Murjani General Hospital being the only hospital in
KotawaringinTimur Regency and covering an area of 16.796 km2 and
405.700 citizens,8,9whichalso resulted ina long clinicwaiting time.A
combination of these factors might have inﬂuenced patients to seek
medical care only in case of severe symptoms or complications, such
as inability to void. Meanwhile, Verhamme et al16 showed that acute
urinary retention (AUR)was the ﬁrst symptomof LUTS/BPH in 49% of
AUR cases that occurred in men newly diagnosed with LUTS/BPH.
Some patients may truly have urinary retention as their ﬁrst symp-
tom. Sexton et al3 and Montorsi and Mercadante11 reported that
nocturia was the most common symptom and its resolutionwas the
top priority in terms of treatment of LUTS/BPH, while in our study
only 3.4% of patients reported nocturia as their chief complaint. This
difference may also be caused by factors inﬂuencing health-seeking
behavior as stated above, but further research may be needed to
elucidate this disparity.
According to current guidelines,17e19 the recommended diag-
nostic evaluations of LUTS by a nonurologist should include med-
ical history, evaluation of symptoms using IPSS, DRE, urinalysis,
and, in patients with indication, FVC, PSA, imaging of the prostate,
and imaging of the upper urinary tract. Contrary to these recom-
mendations, all patients in this study received substandard diag-
nostic evaluations. Even though results from studies in Indonesia6
and Europe11 also showed that IPSS, DRE, urinalysis, and PSA
measurement were not routinely done, the results from this study
were much lower compared to them. In Indonesia and Europe,6,11
respectively, IPSS was used in 44% and 15.4%, respectively,
compared with 1.1% in this study, DRE in 65% and 63.8%, respec-
tively, compared with 3.4%, urinalysis in 19% and 60.8%, respec-
tively, compared with 5.6%, and PSA in 23.5% and 87.9%,
respectively, compared with 0%. This difference may be caused by
the differences in study design and availability of healthcare re-
sources. Those studies used data collected from general practi-
tioners using questionnaires and were conducted in developed
areas with different availability of healthcare resources compared
with the area where this study took place. Possible reasons for the
rare usage of IPSS were that it was considered impractical and time
consuming, especially in a busy practice setting,6 and some phy-
sicians did not ﬁnd it useful for clinical practice.11 Seftel et al20 also
reported that only 41% of primary-care physicians used IPSS to
assess LUTS compared with 81% of urologists. The same reasons as
to why IPSS was rarely used also applied to the rare usage of DRE
and FVC. For PSA measurements, the rare usage may be caused by
its unavailability in the hospital's laboratory and due to the fact that
the fee for examination in private laboratorywas not covered by the
national health insurance. Possible explanations for the high
number of imaging studies compared with other examinations
were as follows: physician's over-reliance on imaging, the process
not being time consuming for the diagnosing physician, and its easy
availability and coverage by the national health insurance.
The comorbid conditions found were in accordance with the
ﬁndings that heart disease, hypertension, asthma, diabetes, and
neurological conditionwere associatedwith LUTS.21,22 Hammarsten
and Hogstedt23 also found that Type 2 diabetes mellitus, hyperten-
sion, and low high-density lipoprotein cholesterol levels were risk
factors for the development of BPH, although the type of dyslipi-
demia found in this study was not clariﬁed. There was neithercontrol group nor epidemiologic data about those diseases in East
Kotawaringin; therefore, the frequency could not be compared.
The appropriateness of the treatment could not be determined
because of the lack of diagnostic evaluations. Severities of symp-
toms, predominant symptoms, bothersome symptoms, and pros-
tate volume were not adequately assessed in almost all patients, so
the algorithm from current guidelines17e19 could not be applied.
Overall, the treatment that was administered most often was
indwelling catheterization (25.8%). Even though catheterization is
the proper initial management for AUR, it should be combined with
a-blockers followed by a trial without catheter (TWOC), and if the
TWOC fails, followed by surgery24,25 or clean intermittent cathe-
terization.24 Patients who were treated by indwelling catheteriza-
tion in this study did not receive any medical treatment and did not
plan to undergo surgical treatment or see a urologist if a TWOC
fails. Explanations why most treatments were stopped at
indwelling catheterization were similar to why most patients pre-
sent late with urinary retention, added by the factors related to
referral advice. As stated above, education level in East Kotawar-
ingin was low,9 so patients might have assumed that their disease,
in the form of urinary retention, was cured by catheterization, as
evidenced by the passage of urine and diminishing pain.
Cunningham-Burley et al13 suggested that fear of surgery is a factor
inﬂuencing decision making regarding consulting a doctor,
although the surgery was of minimally invasive nature if they were
referred to a urologist. This was made worse by the people's
perception that urinary symptoms are a normal part of aging,13e15
so the concept of requiring a surgery or treatment for a condition
that they considered normal was contradictory. Patients who were
referred to a urologist usually had an indication for surgery and
comorbid conditions that increased their surgical risk. However,
among them, only 37.9% visited a urologist after being referred;
therefore, those who refused had limited options, because OP, an
intermediate risk procedurewith reported cardiac risk of 0e8%,26,27
complication rates of 3.5e57.3%,26 and mortality rates of 0e1%,28
was not feasible for those with a high surgical risk, while watch-
ful waiting and medical treatment were unlikely to alleviate the
AUR, leaving indwelling catheterization as the only feasible, albeit
inappropriate, option, as reﬂected by its highest percentages in
those who refused referral.
The abovementioned factors also inﬂuenced a patient's decision
to visit a urologist after being referred, added by other factors. The
nearest urologist to be referred to was in the province's capital,
Palangkaraya, which is about 230 km from Murjani General Hos-
pital. Even though the medical cost was covered by the national
health insurance, transportation and accommodation fees were
not. In addition, only 44.9% of patients had national health insur-
ance and district health insurance could not be used outside of East
Kotawaringin. Loss of time at work as well as loss of potential
earning also contributed.12 These explained why only 17 patients
(19.1%) visited a urologist following a referral, although 37 patients
(41.6%) were advised to do so.
OPwasalmost abandoned in somedevelopedcountries in favorof
other less invasive techniques, although it is still commonly per-
formed in other countries.26 In this study, 12.4% of patients were
treatedbyOP. This ratediffered fromthat in theUSA,where the rateof
OP was only 2.3%.29 It was because OP by a general surgeon was the
only available surgical treatment for BPH inMurjaniGeneral Hospital
and thebarrier for urologist referral as stated above. Even though this
procedure was associated with the highest morbidity rate and the
largest patient burden and cost, itmaintained an outstanding clinical
outcome.26 OP still has a role, and is acceptable in less developed
countries and less wealthy areas, such as in this study.
Two-ﬁfths of the patients in this studyhad an absolute indication
for surgery, mostly in the form of recurrent or refractory urinary
Prostate Int 4 (2016) 65e6968retention. However, only 38.9% of them received appropriate treat-
ment, whether by a general surgeon (16.7%) or a urologist (22.2%).
Half of these patients were treated only by a chronic indwelling
catheter, which is clearly inappropriate in the face of an absolute
indication for surgery. Patients with recurrent or refractory urinary
retention should at least be managed with clean intermittent cath-
eterization if surgery is not possible.24 Successful TWOC became
more difﬁcult to achieve because none of these patients received a-
blockers during their catheterization. Among those refusing the
urologist referral, 35.1% were also managed with indwelling cathe-
terization. Factors inﬂuencing the choice of indwelling catheteri-
zation as a treatment option and a barrier for urologist referral, as
stated above, also explained this treatment pattern.
Factors related to referral advice were mostly indications for
surgery with increased surgical risk. Increased age independently
predicted morbidity and mortality,30 and age > 70 years was one of
the parameters in most cardiac risk indices for noncardiac surgery,
such as Goldman Cardiac Risk Index.31 The contribution of cardio-
vascular disease to perioperative mortality during noncardiac sur-
gery is signiﬁcant,27 and diabetes mellitus with its perioperative
hyperglycemia increases the risks of postoperative mortality and
cardiovascular, respiratory, neurologic, and infectious morbidity.32
The treatment outcome showed that those in the surgical
treatment group reported improvement in 90.9%, and all those
referred to a urologist and returned back to Murjani General Hos-
pital reported improvement after transurethral resection of the
prostate, although only a fraction of patients (23.5%) were available
for follow-up. Studies showed that dissatisfaction rate of patients
treated by OP and transurethral resection of the prostate were 9%
and 15%, respectively.33,34 The loss to follow-up was highest in the
referred group (76.5%), because the referral hospital was not
accessible for data collection as it was outside the coverage area of
this study and the back-referral system was not routinely used.
Those treated with indwelling catheterization reported improve-
ment in 21.8% in terms of ability to void after TWOC without the
need of further catheterization, although none of them received a-
blockers during their catheterization, as stated above. This
contradiction might be caused by the type of AUR the patients had.
In those with spontaneous AUR, 15% had another episode of
spontaneous AUR and 75% underwent surgery, while in those with
precipitated AUR, only 9% had an episode of spontaneous AUR and
26% underwent surgery.35 Unfortunately, the types of AUR that
occurred in patients were not documented; therefore, it could only
be estimated that those with an improvement mostly had precip-
itated AUR. The loss to follow-up rate was also high in the
indwelling catheterization group (34.8%) because the patients in
this group had already rejected other forms of treatment. From
their rejection it can be inferred that their compliance to regular
follow up is low.12 Community health centers and practicing phy-
sicians also provide services such as changing catheters; therefore,
patients may choose them over the hospital due to shorter waiting
time. It is to be noted that the small sample size, subjective
reporting of outcome, and nonuniform length and rate of follow-up
prevented this study's outcome to have a balanced comparison
with data regarding treatment outcome in LUTSeBPH.
This research had some limitations, which are as follows: (1) the
number of samples were inadequate to represent the study's
population; (2) the patients were not diagnosed for LUTS sugges-
tive of BPH using the standard method, so further categorization of
the patients was not complete; and (3) the treatment outcome in
this study was not objectively measured with means such as IPSS,
and the length and rate of follow-up were not uniform.
In summary, when compared with the available guidelines, all
patients received substandard diagnostic evaluations. There was a
pattern of preference toward imaging studies over more basicexamination. The use of core examination for LUTS and BPH, such
as IPSS, FVC, DRE, urinalysis, and PSA, must be improved in Murjani
General Hospital. Overall, the appropriateness of treatment could
not be determined because of the lack of diagnostic evaluations, but
most of the patients with an indication for surgery did not receive
appropriate treatment, in part because most of them refused a
referral to a urologist. The high number of indwelling catheteriza-
tion and inappropriate treatment in those with an indication for
surgery showed the tendency that patients received suboptimal
treatment. The treatment outcome showed more favorable results
in those who were treated appropriately than in those who were
not, but its nonobjective nature and nonuniform follow-up limited
its signiﬁcance. Improvements in various aspects are required to
optimize the management of LUTS suggestive of BPH in Murjani
General Hospital.
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